Tag : neuropathic pain

Latest News

Nanoparticle drug delivery enhances and prolongs pain relief in animal models

Newsemia
An international team of researchers has used nanoparticles to deliver a drug- one that previously failed in clinical trials for pain- into specific compartments of...
Latest News

Protein implicated in neuron growth and cell adhesion appears crucial for pain sensitization

Newsemia
Researchers from Japan’s Osaka University have made an important leap in our understanding of how chronic pain conditions develop. Source link...
Latest News

FDA grants approval for generic versions of Lyrica

Newsemia
On July 19, the U.S. Food and Drug Administration approved multiple applications for first generics of Lyrica (pregabalin) for the management of neuropathic pain associated...
Neurology

Opioids for Chronic Pain Only Nominally Better Than Placebo

Newsemia
Opioids offer marginal pain-control benefits over placebo for patients with chronic pain and "should not be first-line therapy" for pain management, investigators of a new...
Neurology

Repeated CBD Doses Required for Effective Pain Relief

Newsemia
Repeated administration of cannabidiol (CBD) is needed to treat neuropathic pain and related anxiety, according to new research that shows how the drug acts on...
Neurology

Nonopioid Approaches to Pain: The Hunt Is On

Newsemia
As the US opioid epidemic continues to grow, the need to find safe, effective, nonaddictive, nonopioid strategies for managing pain is increasingly urgent, say experts....
Gastroenterology

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Newsemia
Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited announced today that the phase 3 ECHELON-2 clinical trial met its primary endpoint. Source link...
Neurology

Cannabis for Chronic Nerve Pain: Mechanism Revealed?

Newsemia
New imaging findings show the potential mechanism of medical marijuana in providing effective relief from chronic neuropathic pain. Medscape Medical News Source link...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy